MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...

Polaris Pharmaceuticals, Inc. (a subsidiary of Polaris Group) is a biopharmaceutical company specializing in the research and development of novel treatments for cancer. Pegargiminase (ADI-PEG 20 ...

DEPLETING RESERVES: Rapid and unequal usage of natural gas has caused the resource to deplete at an alarming level, and with the population graph rising, access to the resource has become much ...